← Insider Monitor
MAIA Biotechnology, Inc. logo
MAIA

MAIA Biotechnology, Inc.

NYSE · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing telomere-targeting therapies for cancer treatment, with its lead candidate THIO being studied for non-small cell lung cancer and other solid tumors.

Industry
Pharmaceutical Preparations
Headquarters
Chicago, IL
Exchange
NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Guerrero RamiroDirectorBuy$2KAug 24, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for MAIA.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable MAIA activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.